english.prescrire.org > Prescrire International > N°152 - September 2014

n°152

September 2014

Issue Contents
Editorial

Free  Repeating the same mistake

p.200
EMA approval of a second course of varenicline for smoking cessation is unfortunate

Marketing Authorisations


Meningococcal B vaccine (New Drug)

p.201-204
An immunogenic vaccine possibly useful during outbreaks

Development of meningococcal B vaccines

p.204

INN common stem: -gab

p.204

Aflibercept (New Drug)

p.205
Metastatic colorectal cancer: at least as poorly tolerated as bevacizumab

Free  Raltegravir in HIV-infected children at least 2 years of age (New Indication)

p.206
Only after prior treatment failure

Saxagliptin, alone or in combination (New Indication)

p.207
No fewer complications; more cases of heart failure?

Smoking cessation and varenicline

p.208
Do not expose or re-expose patients to its serious adverse effects!

Adverse Effects


Crushing tablets or opening capsules: many uncertainties, some established dangers

p.209-214
Consider and research the impact on the drug's effects

Before crushing a tablet or opening a capsule

p.211

Oral dosage forms

p.212-213

Temozolomide: fatal hepatic failure

p.214
Check liver function tests

Atazanavir: urolithiasis

p.214
Patients need to be briefed

Reviews


Treating essential hypertension

p.215-220
The first choice is usually a thiazide diuretic

The treatment threshold for hypertension

p.219

Editors' Advice

p.220
Antihypertensive treatment for adults without diabetes or cardiovascular or renal disease

Outlook


Free  Health info in doctors' waiting rooms: be selective!

p.221
A survey by a French consumer group

PCB pollutants: reduce consumption of some freshwater fish

p.222-223
Women of child-bearing age, pregnant or breastfeeding women, children under 3, are particularly at risk

Masthead


Free  Masthead

p.198

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe